Reversal of P-gp and BCRP-mediated MDR by tariquidar derivatives
Publication in refereed journal

Times Cited
Web of Science29WOS source URL (as at 13/09/2020) Click here for the latest count
Altmetrics Information

Other information
AbstractWith an aim to generate non-toxic, specific and highly potent multidrug resistance (MDR) modulators, a novel series of anthranilic acid amide-substituted tariquidar derivatives were synthesized. The new compounds were evaluated for their cytotoxicity toward normal human colon fibroblasts (CCD18-Co), human gastric epithelial cell line (HFE) and primary rat liver cells, and for their ability to inhibit P-gp/BCRP-mediated drug efflux and reversal of P-gp and BCRP-mediated MDR in parental and drug-resistant cancer cell lines (LCC6 MDR1, MCF-7 FLV1000, R-HepG2, SW620-Ad300). While tariquidar is highly toxic to normal cells, the new derivatives exhibited much lower or negligible cytotoxicity. Some of the new tariquidar derivatives inhibited both P-gp and BCRP-mediated drug efflux whereas a few of them bearing a sulfonamide functional group (1, 5, and 16) are specific to P-gp. The new compounds were also found to potentiate the anticancer activity of the transporter substrate anticancer drugs in the corresponding transporter-overexpressing cell lines. The extent of resistance reversal was found to be consistent with the transporter inhibitory effect of the new derivatives. To further understand the mechanism of P-gp and BCRP inhibition, the tariquidar derivatives were found to interact with the transporters using an antibody-based UIC2 or 5D3 shift assay. Moreover, the transporters-inhibiting derivatives were found to modulate the ATPase activities of the two MDR transporters. Our data thus advocate further development of the new compounds for the circumvention of MDR. (C) 2015 Elsevier Masson SAS. All rights reserved.
All Author(s) ListLi XQ, Wang L, Lei Y, Hu T, Zhang FL, Cho CH, To KKW
Journal nameEuropean Journal of Medicinal Chemistry
Volume Number101
Pages560 - 572
LanguagesEnglish-United Kingdom
KeywordsAnthranilamide; Breast cancer resistance protein; Multidrug resistance; P-Glycoprotein; Sulfonamide
Web of Science Subject CategoriesChemistry, Medicinal; Pharmacology & Pharmacy

Last updated on 2020-14-09 at 02:18